CyberKnife radiation therapy as a platform for translational mouse studies

Martha Kiljana Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Sabrina Weilb Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany;d Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, GermanyView further author information

Andres Vásquez-Torresa Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Meike Hetticha Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Marimel Mayera Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Olta Ibrulib Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany;d Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, GermanyView further author information

Matthias Reinscheida Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Isabelle Heßelmanna Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Jiali Caia Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Li-na Niua Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Yagmur Sahbazb Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany;d Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, GermanyView further author information

Christian Bauesa Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;d Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, GermanyView further author information

Wolfgang W. Bausa Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Florian Kampa Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Simone Marnitza Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyView further author information

Grit S. Herter-Sprieb Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, Germany;d Department I of Internal Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, GermanyCorrespondence[email protected]
View further author information

Jan M. Hertera Department of Radiation Oncology and CyberKnife Center, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;b Center for Molecular Medicine Cologne, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany;c Center of Integrated Oncology (CIO), Universities of Aachen, Bonn, Cologne, and Duesseldorf, Cologne, GermanyCorrespondence[email protected]
View further author information

show all

CyberKnife radiation therapy as a platform for translational mouse studies

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

CyberKnife radiation therapy as a platform for translational mouse studies

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date